Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China · Delayed Price · Currency is CNY 10.99
+0.01 (0.09%)
Apr 30, 2026, 3:00 PM CST
SHA:603998 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 302.77 | 302.64 | 255.22 | 186.82 | 285.85 | 70.04 |
Depreciation & Amortization | 80.59 | 80.59 | 75.7 | 74.21 | 78.3 | 78.36 |
Other Amortization | 7.82 | 7.82 | 9.15 | 7.34 | 9.82 | 11.36 |
Loss (Gain) From Sale of Assets | -51.39 | -51.39 | -0.75 | -11.53 | 0.9 | 0.07 |
Asset Writedown & Restructuring Costs | 10.41 | 10.41 | 5.43 | 0.28 | 1.31 | 12.81 |
Loss (Gain) From Sale of Investments | -1.69 | -1.69 | -37.74 | 5.46 | -166.18 | 9.46 |
Provision & Write-off of Bad Debts | - | - | -0.81 | 1.18 | 22.6 | 4.66 |
Other Operating Activities | 69.43 | 11.3 | 28.69 | 6.79 | 13.81 | 18.27 |
Change in Accounts Receivable | -62.71 | -62.71 | -54.61 | -78.93 | 196.46 | -62.47 |
Change in Inventory | 32.29 | 32.29 | -62.36 | -24.99 | -46.67 | -46.68 |
Change in Accounts Payable | 57.79 | 57.79 | -30.74 | -86.56 | -114.65 | 87.4 |
Change in Other Net Operating Assets | 0.18 | 0.18 | 3.4 | 18.23 | 12.19 | - |
Operating Cash Flow | 442.89 | 384.63 | 194.95 | 87.54 | 301.63 | 185.63 |
Operating Cash Flow Growth | 160.56% | 97.30% | 122.70% | -70.98% | 62.49% | -21.57% |
Capital Expenditures | -107.16 | -102.52 | -94.79 | -218.78 | -171.25 | -184.71 |
Sale of Property, Plant & Equipment | 2.72 | 2.61 | 28.95 | 9.21 | 1.86 | 0.06 |
Cash Acquisitions | - | - | - | 2.33 | -27.56 | -108.52 |
Divestitures | -0.16 | 24.4 | 22.89 | - | -19.41 | 14.31 |
Investment in Securities | 84.17 | 79.74 | 20.85 | 5.59 | -100.51 | 59.71 |
Other Investing Activities | 47.53 | 77.48 | 1.14 | 1.25 | 2.71 | -10.88 |
Investing Cash Flow | 27.1 | 81.72 | 41.04 | -197.4 | -301.49 | -230.03 |
Short-Term Debt Issued | - | - | - | - | 195.08 | - |
Long-Term Debt Issued | - | 363.4 | 906.66 | 498.9 | 735 | 530.41 |
Total Debt Issued | 378.4 | 363.4 | 906.66 | 498.9 | 930.08 | 530.41 |
Long-Term Debt Repaid | - | -638.55 | -887.16 | -389.77 | -695.3 | -501.73 |
Total Debt Repaid | -561.25 | -638.55 | -887.16 | -389.77 | -695.3 | -501.73 |
Net Debt Issued (Repaid) | -182.85 | -275.15 | 19.51 | 109.13 | 234.78 | 28.68 |
Issuance of Common Stock | - | - | - | 3.33 | 32.26 | - |
Repurchase of Common Stock | - | - | -1.53 | -1.89 | -2.63 | - |
Common Dividends Paid | -231.09 | -193.27 | -129.5 | -174.41 | -123.68 | -46.82 |
Other Financing Activities | -17.73 | -25.69 | -10.47 | -27.7 | -14.15 | 4.02 |
Financing Cash Flow | -431.66 | -494.11 | -122 | -91.55 | 126.58 | -14.13 |
Foreign Exchange Rate Adjustments | -0.11 | -0.09 | - | 0 | -0 | - |
Net Cash Flow | 38.22 | -27.85 | 113.99 | -201.41 | 126.71 | -58.53 |
Free Cash Flow | 335.74 | 282.12 | 100.16 | -131.24 | 130.38 | 0.92 |
Free Cash Flow Growth | 237.28% | 181.67% | - | - | 14138.22% | -98.67% |
Free Cash Flow Margin | 18.74% | 16.15% | 5.63% | -8.06% | 7.28% | 0.06% |
Free Cash Flow Per Share | 0.77 | 0.65 | 0.23 | -0.29 | 0.30 | 0.00 |
Cash Interest Paid | - | - | 0.23 | 0.36 | 0.42 | 0.35 |
Cash Income Tax Paid | 244.71 | 212.97 | 199.83 | 190.24 | 177.97 | 171.02 |
Levered Free Cash Flow | 254.81 | 259.15 | 16.94 | 23.32 | -166.94 | 163.97 |
Unlevered Free Cash Flow | 254.81 | 259.15 | 30.56 | 36.32 | -152.6 | 175.47 |
Change in Working Capital | 24.96 | 24.96 | -139.94 | -183.02 | 55.22 | -19.41 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.